Citation Impact
Citing Papers
Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites
2009 StandoutScience
The Immune Microenvironment Confers Resistance to MAPK Pathway Inhibitors through Macrophage-Derived TNFα
2014
Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis
2008
Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota
2012 StandoutScience
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
2007 StandoutScience
Aire-Dependent Thymic Development of Tumor-Associated Regulatory T Cells
2013 StandoutScienceNobel
Interferon-γ: Biology and Role in Pathogenesis
1996
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
2017 StandoutNature
Hallmarks of Cancer: The Next Generation
2011 Standout
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma
1998
Inflammation-associated cancer: NF-κB is the lynchpin
2005
Hyperplastic gastric tumors induced by activated macrophages in COX‐2/mPGES‐1 transgenic mice
2004
Inflammation and cancer
2002 StandoutNature
Cancer Immunosurveillance and Immunoediting: The Roles of Immunity in Suppressing Tumor Development and Shaping Tumor Immunogenicity
2006
Necroptosis and its role in inflammation
2015 StandoutNature
Role of tumor-associated macrophages in tumor progression and invasion
2006
Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?
1999
Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin–Yang interplay between inflammation and cancer
2010
Ido expression by dendritic cells: tolerance and tryptophan catabolism
2004 Standout
Macrophage polarization in tumour progression
2008
Chemical basis of inflammation-induced carcinogenesis
2003
Extrinsic regulators of epithelial tumor progression: metalloproteinases
2000
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
2013 StandoutNature
Development of Matrix Metalloproteinase Inhibitors in Cancer Therapy
2001
The transcription factor NF-κB: control of oncogenesis and cancer therapy resistance
2000
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
2005 Standout
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Inhibition of NF-κB in cancer cells converts inflammation- induced tumor growth mediated by TNFα to TRAIL-mediated tumor regression
2004
Inflammation as a tumor promoter in cancer induction
2004
Differing effects of endogenous and synthetic inhibitors of metalloproteinases on intestinal tumorigenesis
1998
RalGDS is required for tumor formation in a model of skin carcinogenesis
2005
Blocking TNF-α in mice reduces colorectal carcinogenesis associated with chronic colitis
2008
Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors
2006
Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
2014 StandoutNature
Protease inhibitors: Role and potential therapeutic use in human cancer
1994
The Hallmarks of Cancer
2000 Standout
Human nutrition, the gut microbiome and the immune system
2011 StandoutNature
Proteomic analysis of cytokine induced proteins in human intestinal epithelial cells: Implications for inflammatory bowel diseases
2002
TNF-α is critical for antitumor but not antiviral T cell immunity in mice
2007
Nuclear factor-κB in cancer development and progression
2006 StandoutNature
IKK/NF- B signaling: balancing life and death - a new approach to cancer therapy
2005 Standout
TAK1 Is a Master Regulator of Epidermal Homeostasis Involving Skin Inflammation and Apoptosis
2006
Signalling pathways of the TNF superfamily: a double-edged sword
2003 Standout
Immune-inflammatory mechanisms in IFNγ-mediated anti-tumor activity
2000
The microenvironment of the tumour–host interface
2001 StandoutNature
Oncogenic Ras Diverts a Host TNF Tumor Suppressor Activity into Tumor Promoter
2010
Immunity, Inflammation, and Cancer
2010 Standout
Chronic immune activation and inflammation in the pathogenesis of aids and cancer
2002
Expression of both TNF-α receptor subtypes is essential for optimal skin tumour development
2003
Expression of tumour necrosis factor (TNFα) and its receptors in benign and malignant breast tissue
1994
The role of cytokines in the epithelial cancer microenvironment
2002
Cytokines in cancer pathogenesis and cancer therapy
2004
Inflammation and cancer: back to Virchow?
2001 Standout
Tumour-educated macrophages promote tumour progression and metastasis
2004 Standout
Cancer immunotherapy comes of age
2011 StandoutNature
Matrix metalloproteinase inhibition: A review of anti-tumour activity
1995
TNFR1 Signaling and IFN-γ Signaling Determine whether T Cells Induce Tumor Dormancy or Promote Multistage Carcinogenesis
2008
Paradoxical roles of the immune system during cancer development
2006 Standout
Molecular mechanisms of cancer development in obesity
2011
New aspects of natural-killer-cell surveillance and therapy of cancer
2002
Inflammation and Cancer: Is the Link as Simple as We Think?
2005
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
2012 StandoutNatureNobel
Tumour necrosis factor and cancer
2009
Cancer and the chemokine network
2004 Standout
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
NF-κB functions as a tumour promoter in inflammation-associated cancer
2004 StandoutNature
Tumor necrosis factor or tumor promoting factor?
2002
Ras, PI(3)K and mTOR signalling controls tumour cell growth
2006 StandoutNature
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Tumour necrosis factor-α mediates tumour promotion via a PKCα- and AP-1-dependent pathway
2002
Cancer-related inflammation
2008 StandoutNature
Interleukin-1—a major pleiotropic cytokine in tumor–host interactions
2002
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
2016 StandoutNobel
Cancer-related inflammation: Common themes and therapeutic opportunities
2011
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
2007 StandoutNature
Changing views of the role of matrix metalloproteinases in metastasis
1997
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
2009 Standout
Tumour necrosis factor α: a potential target for the therapy of solid tumours
2003
MK2 regulates the early stages of skin tumor promotion
2009
Tumors and inflammatory infiltrates: Friends or foes?
2002
NF-κB: linking inflammation and immunity to cancer development and progression
2005 Standout
Interferon-γ: an overview of signals, mechanisms and functions
2003 Standout
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
2000
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
2006 StandoutScience
A systems approach to cancer therapy
1996
Crucial Role of Phospholipase Cε in Chemical Carcinogen-Induced Skin Tumor Development
2004
Molecular insights into cancer invasion: strategies for prevention and intervention.
1995
IL-23 suppresses innate immune response independently of IL-17A during carcinogenesis and metastasis
2010
Natural Innate and Adaptive Immunity to Cancer
2011 Standout
Programmed assembly of 3-dimensional microtissues with defined cellular connectivity
2009 StandoutNobel
A Phase II Study of Etanercept (Enbrel), a Tumor Necrosis Factor α Inhibitor in Patients with Metastatic Breast Cancer
2004
RAGE signaling sustains inflammation and promotes tumor development
2008
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Essential roles of tumor necrosis factor receptor p55 in liver metastasis of intrasplenic administration of colon 26 cells.
2002
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
2008 StandoutNobel
Characterizing tumor-promoting T cells in chemically induced cutaneous carcinogenesis
2007
Tryptophan and the immune response
2003
Tumor necrosis factor receptor 1-mediated signaling is required for skin cancer development induced by NF-κB inhibition
2004
IFNγ Promotes Papilloma Development by Up-regulating Th17-Associated Inflammation
2009
Matrix Metalloproteinase Inhibitor COL-3 in the Treatment of AIDS-Related Kaposi's Sarcoma: A Phase I AIDS Malignancy Consortium Study
2002
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
2002 StandoutScience
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
2005 StandoutScience
Neurodegenerative and Neuroprotective Effects of Tumor Necrosis Factor (TNF) in Retinal Ischemia: Opposite Roles of TNF Receptor 1 and TNF Receptor 2
2002
Suppression of Lymphoma and Epithelial Malignancies Effected by Interferon γ
2002
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
2005 Standout
Hyperplastic Gastric Tumors with Spasmolytic Polypeptide–Expressing Metaplasia Caused by Tumor Necrosis Factor-α–Dependent Inflammation in Cyclooxygenase-2/Microsomal Prostaglandin E Synthase-1 Transgenic Mice
2005
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
Interferons, immunity and cancer immunoediting
2006
Marimastat as First-Line Therapy for Patients With Unresectable Pancreatic Cancer: A Randomized Trial
2001
Immune recognition and tumor protection
2002
Indoleamine 2,3-Dioxygenase Expression in Transplanted NOD Islets Prolongs Graft Survival After Adoptive Transfer of Diabetogenic Splenocytes
2002
Innate or Adaptive Immunity? The Example of Natural Killer Cells
2011 StandoutScience
Inhibition of Methylcholanthrene-induced Carcinogenesis by an Interferon γ Receptor–dependent Foreign Body Reaction
2002
Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides
2020 StandoutNobel
Structure and Function of DNA Photolyase and Cryptochrome Blue-Light Photoreceptors
2003 StandoutNobel
Works of N East being referenced
Changes in endogenous cytokines, adhesion molecules and platelets during cytokine-induced tumour necrosis
1995
Cells secreting tumour necrosis factor show enhanced metastasis in nude mice
1990
THE role of indoleamine 2,3‐dioxygenase in the anti‐tumour activity of human interferon‐γ in vivo
1995
Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis
1999
An anti-tumor necrosis factor-alpha antibody inhibits the development of experimental skin tumors.
2003
A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts.
1993